Phio Pharmaceuticals (PHIO): Sotuvning operatsion marjasi

Phio Pharmaceuticals Corp (PHIO) - korporativ logo

Phio Pharmaceuticals qattiq o'smalarga qarshi kurashish uchun INTASYL platformasini joriy etmoqda, bu esa intensiv tadqiqot xarajatlarini va moliyaviy bosimni keltirib chiqaradi. Operatsion marja taqsimoti ushbu xarajatlarni aniq aks ettiradi, bunda 0.00 joriy metrika darajasi vazifasini o'taydi. Vaziyat noyob RNA terapiyasini yetkazib berish usuli bilan barqarorlashtirilgan bo'lib, bu kompaniyaga sog'liqni saqlash gigantlaridan sezilarli royalti to'lovlarini olish imkonini beradi.

PHIO - Phio Pharmaceuticals Corp Operatsion foyda koeffitsiyenti 04.07.2022 - 19.11.2026 oraligʻida

Phio Pharmaceuticals kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning asosiy tahlili:PHIO, Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. tayyor mahsulotlari

Tor immunoonkologiya nishalarida raqobatlashadigan kichik kapitalizatsiyali biotexnologiya kompaniyasi Phio Pharmaceuticals (PHIO) uchun operatsion marja dinamikasi ishlanishning erta bosqichlaridagi xarajatlarni boshqarish samaradorligining ko'rsatkichi bo'lib xizmat qiladi. Ushbu ko'rsatkich har bir dollar daromad ichidagi foizlar va soliqlar to'lanishidan oldingi operatsion foyda qismini belgilaydi, bu esa investorlarga qarz yuklamasi yoki soliq rejimidan qat'i nazar, biznes modelining haqiqiy daromadliligini baholash imkonini beradi.

Muhim raqobatchilar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|Sotuvning operatsion marjasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Operatsion marja|Boundless Bio Inc. (BOLD) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi XCUR (exicuretx.com)|Imunon Inc - Operatsion foyda bo'yicha sotuv rentabelligi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik